Muscular Atrophy

"Muscular Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.

Descriptor ID	D009133
MeSH Number(s)	C10.597.613.612 C23.300.070.500 C23.888.592.608.612
Concept/Terms	Muscular Atrophy Muscular Atrophy Atrophies, Muscular Atrophy, Muscular Muscular Atrophies Atrophy, Muscle Atrophies, Muscle Muscle Atrophies Muscle Atrophy Neurogenic Muscular Atrophy Neurogenic Muscular Atrophy Atrophies, Neurogenic Muscular Atrophy, Neurogenic Muscular Muscular Atrophies, Neurogenic Muscular Atrophy, Neurogenic Neurogenic Muscular Atrophies Neurotrophic Muscular Atrophy Atrophies, Neurotrophic Muscular Atrophy, Neurotrophic Muscular Muscular Atrophies, Neurotrophic Muscular Atrophy, Neurotrophic Neurotrophic Muscular Atrophies

Below are MeSH descriptors whose meaning is more general than "Muscular Atrophy".

Diseases [C]
Nervous System Diseases [C10]
Neurologic Manifestations [C10.597]
Neuromuscular Manifestations [C10.597.613]
Muscular Atrophy [C10.597.613.612]
Pathological Conditions, Signs and Symptoms [C23]
Pathological Conditions, Anatomical [C23.300]
Atrophy [C23.300.070]
Muscular Atrophy [C23.300.070.500]
Signs and Symptoms [C23.888]
Neurologic Manifestations [C23.888.592]
Neuromuscular Manifestations [C23.888.592.608]
Muscular Atrophy [C23.888.592.608.612]

Below are MeSH descriptors whose meaning is related to "Muscular Atrophy".

Below are MeSH descriptors whose meaning is more specific than "Muscular Atrophy".

Muscular Atrophy
Sarcopenia

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Muscular Atrophy" by people in this website by year, and whether "Muscular Atrophy" was a major or minor topic of these publications.

Bar chart showing 19 publications over 12 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2003	1	0	1
2004	0	1	1
2006	1	1	2
2008	1	0	1
2010	1	0	1
2014	1	0	1
2016	1	1	2
2017	1	1	2
2019	1	2	3
2020	1	1	2
2022	1	1	2

Below are the most recent publications written about "Muscular Atrophy" by people in Profiles.

Schwartz LM, Gundersen K. Cross Talk opposing view: Myonuclei do not undergo apoptosis during skeletal muscle atrophy. J Physiol. 2022 05; 600(9):2081-2084.

View in: PubMed
Jagannathan S, de Greef JC, Hayward LJ, Yokomori K, Gabellini D, Mul K, Sacconi S, Arjomand J, Kinoshita J, Harper SQ. Meeting report: the 2021 FSHD International Research Congress. Skelet Muscle. 2022 01 17; 12(1):1.

View in: PubMed
Tsuji J, Thomson T, Chan E, Brown CK, Oppenheimer J, Bigelow C, Dong X, Theurkauf WE, Weng Z, Schwartz LM. High-resolution analysis of differential gene expression during skeletal muscle atrophy and programmed cell death. Physiol Genomics. 2020 10 01; 52(10):492-511.

View in: PubMed
Judge SM, Deyhle MR, Neyroud D, Nosacka RL, D'Lugos AC, Cameron ME, Vohra RS, Smuder AJ, Roberts BM, Callaway CS, Underwood PW, Chrzanowski SM, Batra A, Murphy ME, Heaven JD, Walter GA, Trevino JG, Judge AR. MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer. Cancer Res. 2020 05 01; 80(9):1861-1874.

View in: PubMed
Yang X, Brobst D, Chan WS, Tse MCL, Herlea-Pana O, Ahuja P, Bi X, Zaw AM, Kwong ZSW, Jia WH, Zhang ZG, Zhang N, Chow SKH, Cheung WH, Louie JCY, Griffin TM, Nong W, Hui JHL, Du GH, Noh HL, Saengnipanthkul S, Chow BKC, Kim JK, Lee CW, Chan CB. Muscle-generated BDNF is a sexually dimorphic myokine that controls metabolic flexibility. Sci Signal. 2019 08 13; 12(594).

View in: PubMed
Zhong X, Pons M, Poirier C, Jiang Y, Liu J, Sandusky GE, Shahda S, Nakeeb A, Schmidt CM, House MG, Ceppa EP, Zyromski NJ, Liu Y, Jiang G, Couch ME, Koniaris LG, Zimmers TA. The systemic activin response to pancreatic cancer: implications for effective cancer cachexia therapy. J Cachexia Sarcopenia Muscle. 2019 10; 10(5):1083-1101.

View in: PubMed
Dominov JA, Uyan ?, McKenna-Yasek D, Nallamilli BRR, Kergourlay V, Bartoli M, Levy N, Hudson J, Evangelista T, Lochmuller H, Krahn M, Rufibach L, Hegde M, Brown RH. Correction of pseudoexon splicing caused by a novel intronic dysferlin mutation. Ann Clin Transl Neurol. 2019 Apr; 6(4):642-654.

View in: PubMed
Godfrey ND, Dowlatshahi S, Martin MM, Rothkopf DM. Wieacker-Wolff syndrome with associated cleft palate in a female case. Am J Med Genet A. 2018 01; 176(1):167-170.

View in: PubMed
Yenigun VB, Sirito M, Amcheslavky A, Czernuszewicz T, Colonques-Bellmunt J, Garc?a-Alcover I, Wojciechowska M, Bolduc C, Chen Z, L?pez Castel A, Krahe R, Bergmann A. (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis. Dis Model Mech. 2017 08 01; 10(8):993-1003.

View in: PubMed
Yang C, Danielson EW, Qiao T, Metterville J, Brown RH, Landers JE, Xu Z. Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity. Proc Natl Acad Sci U S A. 2016 10 11; 113(41):E6209-E6218.

View in: PubMed

People

Explore

Similar Concepts

Top Journals